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Results: In the whole population, CDA Lys27Lys polymorphism sig-
niﬁcantly correlated with better response (P=0.04) and higher haemato-
logical toxicity. In the cisplatin/gemcitabine-treated patients, signiﬁcant 
correlations were observed between CDA Lys27Lys genotype and 
better response, grade >3 neutropenia, as well as with longer TTP and 
OS (P=0.01 and P=0.001, respectively) (Table 1).
Table 1. Correlation between CDA 27 genotype SNP and activity, eﬃcacy 
and haematological toxicity of chemotherapy.
The multivariate analysis conﬁrmed the prognostic signiﬁcance of this 
polymorphism (P=0.02), while no signiﬁcant associations were found 
among ERCC1 and XPD polymorphisms and clinical outcome in this 
group of patients. CDA genotype didn’t result predictive of response 
and toxicity in patients treated with gemcitabine alone.
Conclusions: CDA Lys27Gln polymorphism resulted a predictive 
biomarker of response rate, toxicity, TTP and OS in advanced NSCLC 
patients treated with cisplatin and gemcitabine, thus offering a potential 
new tool for treatment optimization. Enzymatic activity assays on 
blood samples are ongoing to better understand this feature.
This work was partly supported by the Fondazione A.R.C.O.
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Background: Phospholipase D (PLD) is activated by stimulators of 
vesicle transport, endocytosis, exocyosis, cell migration, and mitosis. 
These cellular biological processes are deregulated in the development 
of various human tumors. The involvement of PLD in tumorigenesis 
suggests that PLD could be valuable targets for therapeutic interven-
tion and phamacogenetics focuses on the prediction of the effect 
of chemotherapy by genetic proﬁling in cancers. Single nucleotide 
polymorphisms (SNPs) are extensively used in case-control studies of 
practically all cancer. The identiﬁcation of polymorphisms of cancer 
patients may help the clinician prescribe the optimal drug combination 
or schedule and predict the response of chemotherapy with accuracy.
Method: The purpose of this study was to analyze genetic polymor-
phisms of phospholipase D1(PLD1) gene as a predictive marker for 
response to chemotherapy in non-small cell lung cancer. 
Results: We identiﬁed two SNPs at the exon 14, one SNP at the exon 
16 and six SNPs at the exon 23. cSNPs of PLD1 was selected ac-
cording to the degree of heterozygosity; (exon 23, rs2668, allele A/C: 
A2668C). The allelic frequencies of A2668C was 70.85 % in 211 non-
small lung cancer patients. The allelic frequencies of A2668C polymor-
phism of responders (partial response) showed signiﬁcant association 
with non-responders (stable disease and progression) to chemotherapy 
(p=0.059, OR=1.739). Also, the genotype frequencies of A2668C poly-
morphism of responders showed signiﬁcant association with non-re-
sponders to chemotherapy (p=0.017, OR=2.198). Between gender and 
smoking on the risk of lung cancer, signiﬁcant association was found in 
genotype frequencies of A2668C polymorphism (p=0.013, OR=2.651). 
Conclusion: From our results, we suggest that PLD1 genetic polymor-
phism (A2668C) might be a predictive marker for response to chemo-
therapy in non-small cell Lung cancer. 
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Correlation between high-resolution CT findings, histopathological 
and clinical findings of small pulmonary adenocarcinomas
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Background: Previously, we reported that small pulmonary adenocar-
cinomas (tumor diameter 20mm or less) could be classiﬁed according 
to attenuation on high-resolution CT (HRCT) images as either ‘air-con-
taining type’ (‘fair-type’) or ‘solid-density type’ (=’solid-type’) (Lung 
Cancer 36 (2002)). Air-type was deﬁned as having areas where tumor 
opacity on mediastinal window images were half or less than half the 
size of those noted on lung window images. Solid-type was deﬁned as 
having areas where tumor opacity on mediastinal window images was 
greater than half the size of those noted on lung window images. Our 
ﬁndings indicated that there was no microscopic evidence of metastasis 
with air-type nor any relapses nor deaths, after resection. By contrast, 
patients with solid-types demonstrated a poor prognosis. At this time, 
the histopathological characteristics of areas of tumor opacity noted on 
mediastinal window images have not been fully investigated.
Method: We retrospectively reviewed the records and CT scans of 118 
patients, who had undergone surgical resection of peripheral adeno-
carcninomas. All tumor diameters were 20mm or less in size. All 118 
patients had undergone HRCT prior to surgery. HRCT Images were 
acquired by a model X-Vigor/Real or an Aquillion CT scanner (Toshiba 
Medical Systems). High-resolution images of tumors were obtained at 
135kVp at 250mAs with 1-2mm section thicknesses. All images were 
photographed using mediastinal (level, 40HU; width, 400HU) and lung 
(level, -600HU; width, 1600HU) window settings. We analyzed the 
correlation between areas of tumor opacity of mediastinal window im-
ages and the histopathological and the clinical ﬁndings.
Results: Areas of tumor opacity noted on mediastinal window images 
demonstrated ﬁve possible histopathological ﬁndings; 1. collapse (C), 
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2. collapse with bronchioalveolarcell carcinoma (CwB), 3. adenocar-
cinoma cells (Cells), 4. ﬁbroblasts (F), and 5. mucus (M). Areas of 
air-type adenocarcinomas (in 49 cases) demonstrated predominantly 
C and/or CwB (C/CwB type: in 46 cases). Areas of solid-type adeno-
carcinomas (in 69 cases), in comparison, demonstrated predominantly 
Cells and/or Cells/F (Cells/F type: in 66 cases). We noted a statistically 
signiﬁcant difference between the histopathological ﬁndings of the 
areas of tumor opacity on mediastinal window images of air-type and 
solid-type tumors. In 34 cases, Cells/F type adenocarcinomas revealed 
microscopic evidence of metastasis (pleural involvement, vascular 
invasion, lymphatic permeation, or lymphnode metastsis). Whereas, no 
C/CwB type adenocarcinomas cases revealed any microscopic metasta-
sis. The prognosis of C/CwB after resection is better than for Cells/F.
Conclusion: We found that ‘Air-type’ adenocarcinomas demonstrated 
C/CwB type, and that ‘Solid-type’ adenocarcinomas demonastrated 
Cells/F type. We concluded that the histopathological ﬁndings of small 
pulmonary adenocarcinomas could be classiﬁed into two groups: 
C/CwB type and Cells/F type. The prognosis of C/CwB is better than 
for Cells/F.
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Background: The development of Lung Carcinoma (LC) is accompa-
nied by ﬁeld changes of histological and chromosomal abnormalities in 
the airway mucosa. Neither histological grade nor markers of chro-
mosomal abnormalities in preneoplastic epithelial lesions have been 
adequately validated as predictors of invasive LC. 
Methods: Histological dysplasia score and chromosomal aneusomy 
measured by FISH analysis were compared as correlates of invasive 
LC in a case-control study of 44 individuals with LC (cases) and 90 
individuals without LC (controls). We used bronchial biopsy samples 
from subjects found by LIFE or white light bronchoscopy to have had 
moderate dysplasia (MD), severe dysplasia (SD) or carcinoma in situ 
(CIS). Tissue samples were reviewed by the study pathologist, the 
grades of preneoplastic change were veriﬁed and the appropriate areas 
in each histological slide were selected for FISH analysis. A 4-color 
FISH probe was used for aneusomy detection targeting centromere 6, 
5p15.2, 7p12 (EGFR) and 8q24 (CMYC). Three or more copies for two 
or more of these DNA targets indicated an aneusomic cell. Premalig-
nant lesions were classiﬁed as aneusomic when displaying aneusomic 
cells above the threshold deﬁned in normal bronchial epithelium (mean 
+ 3 SD). 
Results: The population included 104 males and 30 females with a 
mean age of 64 years and a mean smoking history of 62 pack-years. 
There was no difference in mean age, sex distribution or pack-years 
of smoking between LC cases and controls, but cases had a higher 
frequency of current smokers (p=0.05). Thirty two had CIS as the 
highest histological grade of mucosal abnormality, 48 had SD and 54 
MD. The strongest correlate with invasive LC was CIS by histological 
examination (OR=12.5, 95% CI 4.1 to 38.1). Chromosomal aneusomy 
was seen in 64% of the LC cases but in only 31% of the controls. (OR 
= 4.6, 95% CI 2.0 to 10.9). The proportion of subjects with chromo-
somal aneusomy increased from moderate dysplasia (22.2%) to severe 
dysplasia (41.7%) and CIS lesions (71.9%) and showed a similar trend 
for cases and controls. Presence of aneusomy slightly increased the risk 
for LC in MD (OR=1.91, 95% CI 0.26 to 13.8) but was a substantial 
impacting factor in subjects with SD (OR=7.06, 95% CI 0.82 to 60.1) 
and CIS (OR=5.93, 95% CI 0.5 to 69.7).
Conclusions: CIS on histological examination and abnormal FISH 
analysis are both associated with lung cancer cross-sectionally. Future 
studies need to examine these biomarkers prospectively, and to assess 
their interaction in predicting lung cancer risk. 
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SCF protein (Skp2, CUL1) regulate the E2F1 dependent 
transcriptional activity and cyclin E in human lung tumors
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Background: The E2F1 transcription factor is a cell cycle and onco-
genic protein which plays ambiguous role in promoting proliferation 
or apoptosis depending on histological cell type of lung cancer (Salon 
et al. Cell Death and Differ. 2006). Accordingly, its activity is tightly 
controlled by transcriptional and post-transcriptional events in which 
the ubiquitin-proteasome pathway mediated by SCF complexes such 
as Skp2 and Cullin 1 (CUL1) proteins play a role in its degradation. 
We have previously identiﬁed differential pattern of E2F1 protein 
expression in human lung cancer with high expression in high grade 
neuroendocrine tumors, in contrast with low or no expression in non 
small cell carcinoma and in carcinoids (small cell lung carcinoma and 
large cell neuroendocrine carcinoma) (Eymin et al. Oncogene 2001). 
In order to investigate the role of proteasome degradation in E2F1 
expression and activity we analyzed the components of SCF complex 
(Skp2 and CUL1) to understand their role on expression of E2F1 and 
its transcriptional targets cyclin E, important regulators of cell cycle at 
G1-S transition.
Methods: Using immunohistochemistry and immunoblotting we ana-
lyzed 128 lung tumors of all histological types for the relationship link-
ing E2F1 and two components CUL1 and Skp2 of the ubiquitin-protein 
ligase SCFSkp2 <involved in E2F1 proteolysis and the consequence on 
cyclin E level expression.
Results: Skp2 protein was more often overexpressed in high grade neu-
roendocrine (HGNE) carcinoma (46/54; 86 %) than in NSCLC (16/50; 
32 %) (p<0.0001), and undetectable in 25/25 carcinoids. Overexpres-
sion of E2F1 and Skp2 proteins were directly correlated in HGNE 
tumors where Skp2 overexpression was correlated with advanced stage 
(p<0.0001) and nodal metastasis (p<0.0001). There was a signiﬁcant 
correlation between Skp2 and Ki67 across histological types (p=0.01). 
No correlation was found between E2F1 and CUL1. In in vitro cellular 
models we provided evidence that Skp2 is a novel transcriptional target 
of E2F1. Skp2 interacts with E2F1 and stimulates its transcriptional 
activity toward the cyclin E promoter. Consistently, we found a cor-
relation between Skp2 and cyclin E (p<0.0001) and between E2F1 and 
cyclin E in neuroendocrine lung tumors (p=0.0001). In contrast, CUL1 
